{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:50:06Z","timestamp":1777719006171,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,12,11]],"date-time":"2007-12-11T00:00:00Z","timestamp":1197331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/sj.ijo.0803777","type":"journal-article","created":{"date-parts":[[2007,12,11]],"date-time":"2007-12-11T11:27:23Z","timestamp":1197372443000},"page":"692-699","source":"Crossref","is-referenced-by-count":44,"title":["Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study"],"prefix":"10.1038","volume":"32","author":[{"given":"D","family":"Florakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Diamanti-Kandarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Katsikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G P","family":"Nassis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Karkanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Panidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,11]]},"reference":[{"key":"BF0803777_CR1","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","volume":"84","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Berqiele AT, Filandra FA, Tsianateli TC, Spina GG et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006\u20134011.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41\u201347.","journal-title":"Hum Reprod"},{"key":"BF0803777_CR3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"AD Ehrmann","year":"2005","unstructured":"Ehrmann AD . Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223\u20131236.","journal-title":"N Engl J Med"},{"key":"BF0803777_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","volume":"14","author":"S Sam","year":"2003","unstructured":"Sam S, Dunaif A . Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 2003; 14: 365\u2013370.","journal-title":"Trends Endocrinol Metab"},{"key":"BF0803777_CR5","first-page":"2434","volume":"85","author":"M Asuncion","year":"2000","unstructured":"Asuncion M, Calvo RM, San Millan JL, Sancho J, Avilas S, Escobar-Morreale HF . A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434\u20132438.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1210\/jcem-65-3-499","volume":"65","author":"A Dunaif","year":"1987","unstructured":"Dunaif A, Graf M, Mandeli J, Laumas V, Dobrajansky A . Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and\/or hyperinsulinemia. J Clin Endocrinol Metab 1987; 65: 499\u2013507.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/diacare.22.1.141","volume":"22","author":"DA Ehrmann","year":"1999","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J . Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141\u2013146.","journal-title":"Diabetes Care"},{"key":"BF0803777_CR8","first-page":"165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A . Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165\u2013169.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","volume":"15","author":"E Talbott","year":"1995","unstructured":"Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 1995; 15: 821\u2013826.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF0803777_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3109\/00016349209006227","volume":"71","author":"E Dahlgren","year":"1992","unstructured":"Dahlgren E, Johansson S, Johansson L, Lapidus L, Oden A . Polycystic ovary syndrome and risk for myocardial infraction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 1992; 71: 599\u2013604.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"BF0803777_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","volume":"51","author":"T Pierpoint","year":"1998","unstructured":"Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS . Mortality of women with PCOS at long-term follow-up. J Clin Epidemiol 1998; 51: 581\u2013586.","journal-title":"J Clin Epidemiol"},{"key":"BF0803777_CR12","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1210\/jc.2005-0011","volume":"90","author":"C Meyer","year":"2005","unstructured":"Meyer C, McGrath BP, Teede HJ . Overweight women with polycystic ovary syndrome have evidence of sub clinical cardiovascular disease. J Clin Endocrinol Metab 2005; 90: 5711\u20135716.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","volume":"32","author":"DS Kiddy","year":"1990","unstructured":"Kiddy DS, Sharp PS, White DM, Scalon MF, Mason HD, Bray CS et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol 1990; 32: 213\u2013220.","journal-title":"Clin Endocrinol"},{"key":"BF0803777_CR14","first-page":"2691","volume":"84","author":"MM Huber-Buchholz","year":"1999","unstructured":"Huber-Buchholz MM, Carey DG, Norman RJ . Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84: 2691\u20132695.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR15","first-page":"2586","volume":"80","author":"J Holte","year":"1995","unstructured":"Holte J, Bergh T, Berne C, Wide L, Lithell H . Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80: 2586\u20132593.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0026-0495(95)90118-3","volume":"44","author":"P Andersen","year":"1995","unstructured":"Andersen P, Seljeflot I, Abdelnoor M, Arnesen H, Dale PO, Lovik A et al. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism 1995; 44: 611\u2013616.","journal-title":"Metabolism"},{"key":"BF0803777_CR17","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","volume":"13","author":"AM Clark","year":"1998","unstructured":"Clark AM, Thornley B, Tomlinson L, Galletly C, Norman RJ . Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998; 13: 1502\u20131505.","journal-title":"Hum Reprod"},{"key":"BF0803777_CR18","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/jc.2002-020815","volume":"88","author":"LJ Moran","year":"2003","unstructured":"Moran LJ, Noakes M, Clifton PM, Tomlinson L, Galletly C, Norman RJ . Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 812\u2013819.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","volume":"13","author":"RJ Norman","year":"2002","unstructured":"Norman RJ, Davies MJ, Lord J, Moran LJ . The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002; 13: 251\u2013257.","journal-title":"Trends Endocrinol Metab"},{"key":"BF0803777_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0015-0282(16)48154-9","volume":"42","author":"FE Harlass","year":"1984","unstructured":"Harlass FE, Plymate SR, Fariss BL, Belts RP . Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril 1984; 42: 649\u2013652.","journal-title":"Fertil Steril"},{"key":"BF0803777_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","volume":"36","author":"D Kiddy","year":"1992","unstructured":"Kiddy D, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992; 36: 105\u2013111.","journal-title":"Clin Endocrinol"},{"key":"BF0803777_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1210\/jc.2004-0176","volume":"90","author":"V Jayagopal","year":"2005","unstructured":"Jayagopal V, Kilpatrick ES, Holding S, Jennings PE, Atkin SL . Orlistat is as beneficial as metformin in the treatment of polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 729\u2013733.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR23","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","volume":"85","author":"R Pasquali","year":"2000","unstructured":"Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85: 2767\u20132774.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0015-0282(03)02162-9","volume":"80","author":"T Sabuncu","year":"2003","unstructured":"Sabuncu T, Harma M, Harma M, Nazligul Y, Kilic F . Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome. Fertil Steril 2003; 80: 1199\u20131204.","journal-title":"Fertil Steril"},{"key":"BF0803777_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"D Matthews","year":"1985","unstructured":"Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412\u2013419.","journal-title":"Diabetologia"},{"key":"BF0803777_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/meta.2002.31975","volume":"51","author":"JE Morley","year":"2002","unstructured":"Morley JE, Patrick P, Perry III HM . Evaluation of assays available to measure free testosterone. Metabolism 2002; 51: 554\u2013559.","journal-title":"Metabolism"},{"key":"BF0803777_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ajcn\/68.6.1180","volume":"68","author":"LD Hansen","year":"1998","unstructured":"Hansen LD, Toubro S, Stock JM, Macdoland AI, Astrup A . Thermogenic effects of sibutramine in humans. Am J Clin Nutr 1998; 68: 1180\u20131186.","journal-title":"Am J Clin Nutr"},{"key":"BF0803777_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2265.1992.tb02261.x","volume":"36","author":"S Robinson","year":"1992","unstructured":"Robinson S, Chan SP, Franks S . Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocirnol 1992; 36: 535\u2013536.","journal-title":"Clin Endocirnol"},{"key":"BF0803777_CR29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1463-1326.2005.00465.x","volume":"7","author":"AN Faria","year":"2005","unstructured":"Faria AN, Ribeiro Filho FF, Kohlmann NE, Gouvea Ferreira SR, Zanella MT . Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients. Diabetes Obes Metab 2005; 7: 246\u2013253.","journal-title":"Diabetes Obes Metab"},{"key":"BF0803777_CR30","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1210\/jcem.87.4.8420","volume":"87","author":"AM Rodrigues","year":"2002","unstructured":"Rodrigues AM, Radominski RB, Suplicy Hde L, De Almeida SM, Niclewicz PA, Boguszewski CL . The cerebrospinal fluid\/serum leptin ratio during pharmacological therapy for obesity. J Clin Endocrinol Metab 2002; 87: 1621\u20131626.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/jc.2002-020815","volume":"88","author":"LJ Moran","year":"2003","unstructured":"Moran LJ, Noakes M, Clifton PM, Tomlinson L, Norman RJ . Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 812\u2013819.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0803777_CR32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","volume":"81","author":"K Stamets","year":"2004","unstructured":"Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS . A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 2004; 81: 630\u2013637.","journal-title":"Fertil Steril"},{"key":"BF0803777_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00592-004-0158-7","volume":"41","author":"T Tankova","year":"2004","unstructured":"Tankova T, Dakovska G, Lazarova M, Dakovska L, Kirilov G, Koev D . Sibutramine in the treatment of obesity in type 2 diabetic patients and in nondiabetic subjects. Acta Diabetol 2004; 41: 146\u2013153.","journal-title":"Acta Diabetol"},{"key":"BF0803777_CR34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1463-1326.2003.00285.x","volume":"5","author":"M Tambascia","year":"2003","unstructured":"Tambascia M, Geloneze B, Repetto E, Geloneze S, Picolo M, Magro D . Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trial. Diabetes Obes Metab 2003; 5: 338\u2013344.","journal-title":"Diabetes Obes Metab"},{"key":"BF0803777_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0889-8545(05)70186-8","volume":"28","author":"N Bracero","year":"2001","unstructured":"Bracero N, Zacur HA . Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am 2001; 28: 77\u201384.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"BF0803777_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/sj.ijo.0802887","volume":"29","author":"J Jordan","year":"2005","unstructured":"Jordan J, Scholze J, Matiba B, Wirth A, Hauner H, Sharma AM . Influence of sibutramine on blood pressure: evidence from placebo-controlled trials. Int J Obes (London) 2005; 29: 509\u2013516.","journal-title":"Int J Obes (London)"},{"key":"BF0803777_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000047310","volume":"94","author":"BP Hazenberg","year":"2000","unstructured":"Hazenberg BP . Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients. Cardiology 2000; 94: 152\u2013158.","journal-title":"Cardiology"},{"key":"BF0803777_CR38","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/oby.2003.152","volume":"11","author":"SH Kim","year":"2003","unstructured":"Kim SH, Lee YM, Jee SH, Nam CM . Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. Obes Res 2003; 11: 1116\u20131123.","journal-title":"Obes Res"},{"key":"BF0803777_CR39","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1373\/49.8.1381","volume":"49","author":"J Taieb","year":"2003","unstructured":"Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 2003; 49: 1381\u20131395.","journal-title":"Clin Chem"},{"key":"BF0803777_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H . Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92: 405\u2013413.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0803777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0803777","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0803777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:43:20Z","timestamp":1684223000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0803777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BF0803777"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0803777","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,11]]}}}